Oklahoma City, Oklahoma; Tax Secured, General Obligation Jan 04

  • ID: 2034157
  • January 2004
  • Region: Oklahoma
  • Standard & Poors
1 of 3

Standard & Poor's Ratings Services assigned its 'AA' rating, and stable outlook, to Oklahoma City, Okla.'s series 2004 GO bonds. The rating reflects the city's: Diverse, expanding regional economic base; Significant ongoing redevelopment in the downtown area, which management expects to spark additional private sector investment; Consistently strong financial management and position; and Low debt levels, coupled with a manageable capital improvement program (CIP). Offsetting factors include the city's: Reliance on sales taxes as the primary operating revenue stream, which impairs revenue flexibility; and Below-average income levels. The city's full faith and credit pledge secures the bonds. Oklahoma City, with a population of about 520,000, is the state capital and the state's primary economic center. The city's economic stability is...

Companies mentioned in this report are:
- Oklahoma City

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Oklahoma City

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our


Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.